Rural Health
News by Topic: Health conditions
Aug 22, 2025 - Discusses the suicide risks for veterans, U.S. Department of Veterans Affairs (VA) services that increase access to healthcare, and secure firearm storage as a means to reduce suicide risk.
Source: VA News
Aug 14, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making technical and typographical corrections to the July 16, 2025, proposed rule.
Source: Federal Register
Aug 5, 2025 - Request for comments from the Health Resources and Services Administration on an information collection titled "Ending the HIV Epidemic (EHE) Initiative Triannual Report OMB No. 0915-0051—Extension." HRSA proposes to revise a footnote to provide clarity on existing instruction. Comments are due October 6, 2025.
Source: Federal Register
FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability
Federal Register
Jul 29, 2025 - The Food and Drug Administration (FDA) has revoked Emergency Use Authorizations issued to Regeneron Pharmaceuticals, Inc., for REGEN-COV (casirivimab and imdevimab administered together); GlaxoSmithKline LLC for sotrovimab; Eli Lilly and Company for bebtelovimab; and AstraZeneca Pharmaceuticals LP for EVUSHELD (tixagevimab co-packaged with cilgavimab). These revocations are effective December 13, 2024.
Source: Federal Register
DOD: TRICARE Coverage of Clinical Trials and Termination of Expanded Access Treatments
Federal Register
Jul 28, 2025 - Notice of final rule from the Department of Defense (DOD) Defense Health Agency (DHA) finalizing provisions published in two interim final rules (IFRs) that temporarily added coverage for the treatment use of investigational drugs under U.S. Food and Drug Administration (FDA)-authorized expanded access (EA) programs when for the treatment of coronavirus disease 2019 (COVID-19) and permitted coverage of National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of COVID-19. Among other things, this rule discusses the DOD's decision not to make permanent the coverage of treatment use of investigational drugs under FDA EA programs while updating language for care associated with their administration and broadens the COVID-19 clinical trial benefit to include coverage of clinical trials sponsored or approved by any National Institutes of Health (NIH) Center or Institute to treat or prevent infectious diseases associated with a pandemic or epidemic. This rule is effective August 27, 2025.
Source: Federal Register
Jul 16, 2025 - Notice of a proposed rule from the Centers for Medicare &
Medicaid Services (CMS) addressing: 1) changes to the
Physician Fee Schedule and Medicare Part B payment
policies; 2) policies for the Medicare Prescription Drug
Inflation Rebate Program under the Inflation Reduction Act
of 2022; 3) the Ambulatory Specialty Model; 4) updates to
the Medicare Diabetes Prevention Program expanded model; 5)
updates to drugs and biological products paid under Part B;
6) Medicare Shared Savings Program requirements; 7) updates
to the Quality Payment Program; 8) updates to policies for
Rural Health Clinics (RHCs) and Federally Qualified Health
Centers (FQHCs); 9) updates to the Ambulance Fee Schedule
regulations; 10) codification of the Inflation Reduction
Act and Consolidated Appropriations Act, 2023 provisions;
and 11) updates to the Medicare Promoting Interoperability
Program. Comments are due on September 12, 2025.
Source: Federal Register
Jul 2, 2025 - Notice of proposed rule from the Centers for Medicare & Medicaid Services (CMS) making changes related to End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for calendar year 2026 and proposing updates to the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury (AKI). Among other things, this rule also proposes updated requirements for the ESRD Quality Incentive Program and modifying and terminating requirements for the ESRD Treatment Choices Model. Comments are due by August 29, 2025.
Source: Federal Register
Jun 26, 2025 - Notice from the Health Resources and Services
Administration (HRSA) seeking comments on an information
collection regarding a form related to the COVID-19
Provider Relief Fund (PRF) and American Rescue Plan (ARP)
rural payment reporting activities. The information
collection is used to assess if statutory and programmatic
requirements are met; conduct audits; report on findings
with respect to the disbursements of PRF and ARP Rural
payments; and for the program evaluation. Comments are due
by August 25, 2025.
Source: Federal Register